| Recruiting | A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albutero Asthma | Phase 3 | 2024-12-12 |
| Completed | Mass Balance Clinical Trial With TEV-56286 Healthy Participants | Phase 1 | 2024-10-08 |
| Recruiting | An Open-label Dose Escalation/Expansion Trial to Evaluate the Safety and Anti-tumor Activity of TEV-56278 Alon Advanced Solid Tumors | Phase 1 | 2024-07-22 |
| Completed | Pharmacokinetic Profile and Safety of Fluticasone Propionate and Albuterol Sulfate in Combination When Compare Asthma | Phase 1 | 2024-05-16 |
| Completed | Safety, Tolerability, and Pharmacokinetic Study of TV-44749 in Chinese Patients With Schizophrenia Schizophrenia | Phase 1 | 2024-03-28 |
| Completed | A Study to Test the Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease Crohn Disease, Colitis, Ulcerative | Phase 2 | 2022-09-30 |
| Completed | A Randomized, Double-Blind, Placebo-Controlled Study With an Open-Label Period on Efficacy and Safety of Frema Migraine | Phase 3 | 2022-09-30 |
| Terminated | A Study to Test if TEV-53275 is Effective in Relieving Asthma Asthma | Phase 2 | 2021-05-04 |
| Completed | A 24-Week Treatment Study to Compare Standard of Care Versus the eMDPI DS in Participants 13 Years or Older Wi Asthma | Phase 4 | 2021-02-16 |
| Completed | A Study to Evaluate the Pharmacokinetics (PK) of Medroxyprogesterone Acetate Following an Injection of TV-4604 Contraception | Phase 1 | 2020-12-14 |
| Completed | A 12-Week Treatment Study to Evaluate the Effectiveness of Albuterol Multidose Dry Powder Inhaler With Integra Asthma | Phase 4 | 2020-10-26 |
| Withdrawn | A Study to Test if Fremanezumab Reduces Pain in Patients With Interstitial Cystitis-Bladder Pain Syndrome Interstitial Cystitis | Phase 2 | 2020-10-15 |
| Terminated | A Study to Test if TEV-48574 is Effective in Relieving Asthma Asthma | Phase 2 | 2020-10-07 |
| Completed | A Study to Test if Fremanezumab is Effective in Preventing Chronic Migraine in Participants 6 to 17 Years of A Migraine | Phase 3 | 2020-09-24 |
| Completed | A Study to Test if Fremanezumab is Effective in Preventing Episodic Migraine in Patients 6 to 17 Years of Age Migraine | Phase 3 | 2020-07-15 |
| Terminated | A Study to Test if TEV-50717 is Safe and Effective in Relieving Abnormal Involuntary Movements in Cerebral Pal Cerebral Palsy, Dyskinetic | Phase 3 | 2020-02-04 |
| Completed | A Study to Evaluate the Efficacy and Safety of Fremanezumab for Preventive Treatment of Migraine in Patients W Migraine, Major Depressive Disorder | Phase 4 | 2019-09-13 |
| Completed | A Study of TEV-50717 (Deutetrabenazine) for the Treatment of Dyskinesia in Cerebral Palsy in Children and Adol Cerebral Palsy, Dyskinetic | Phase 3 | 2019-08-06 |
| Terminated | A Study to Test the Effectiveness and Safety of Fremanezumab on Participants With Fibromyalgia Fibromyalgia | Phase 2 | 2019-07-31 |
| Completed | A Study to Test if TV-46000 is Safe for Maintenance Treatment of Schizophrenia Schizophrenia | Phase 3 | 2019-04-17 |
| Completed | A Study to Evaluate Injection Pain and Local Tolerability Following Subcutaneous (SC) Administration of TV-460 Contraception | Phase 1 | 2019-01-15 |
| Completed | A Study to Test if TEV-50717 is Effective in Relieving Tics Associated With Tourette Syndrome (TS) Tourette Syndrome | Phase 3 | 2018-05-31 |
| Terminated | Evaluation of Safety and Tolerability of Long-term TEV-50717 (Deutetrabenazine) for Treatment of Tourette Synd Tourette Syndrome | Phase 3 | 2018-05-25 |
| Completed | Study to Evaluate TV-46000 as Maintenance Treatment in Adult and Adolescent Participants With Schizophrenia Schizophrenia | Phase 3 | 2018-04-27 |
| Completed | Alternatives for Reducing Tics in Tourette Syndrome (TS): A Study of TEV-50717 (Deutetrabenazine) for the Trea Tourette Syndrome | Phase 2 / Phase 3 | 2018-02-05 |
| Completed | A Study to Test if Fremanezumab Reduces Headache in Participants With Posttraumatic Headache (PTH) Post-Traumatic Headache | Phase 2 | 2017-12-18 |
| Completed | An Efficacy and Safety Study of Fremanezumab in Adults With Migraine Migraine Prophylaxis | Phase 3 | 2017-10-13 |
| Completed | Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Ex Chronic Obstructive Pulmonary Disease | Phase 3 | 2017-09-28 |
| Terminated | Study of the Effect of a 5-Day Regimen of Study Drug on Peripheral Stem Cell Mobilization in Healthy Participa Healthy Participants | Phase 3 | 2017-08-02 |
| Terminated | An Imaging Study Using PET/CT to Characterize the Effect of Intravenous Reslizumab on Airway Inflammation Asthma | Phase 4 | 2017-05-08 |
| Terminated | A Study to Explore the Long-Term Safety and Efficacy of Fremanezumab (TEV-48125) for the Prevention of Cluster Cluster Headache | Phase 3 | 2017-04-27 |
| Terminated | A Study of Reslizumab in Patients 12 Years of Age and Older With Severe Eosinophilic Asthma Eosinophils, Asthma | Phase 3 | 2017-03-10 |
| Completed | A Study to Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eM Asthma | Phase 3 | 2017-02-13 |
| Terminated | A Study to Evaluate the Efficacy and Safety of TEV-48125 (Fremanezumab) for the Prevention of Episodic Cluster Episodic Cluster Headache | Phase 3 | 2017-01-19 |
| Terminated | A Study Comparing the Efficacy and Safety of Fremanezumab (TEV-48125) for the Prevention of Chronic Cluster He Chronic Cluster Headache | Phase 3 | 2017-01-17 |
| Completed | Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone Propionate/Salmeterol M Asthma | Phase 3 | 2016-12-28 |
| Completed | Study to Evaluate Suppression of Ovulation and Pharmacokinetics of Medroxyprogesterone Acetate Following Admin Pregnancy, Contraception | Phase 1 | 2016-10-26 |
| Withdrawn | A Study in Adult Patients With Nonalcoholic Steatohepatitis Who Also Have Type 2 Diabetes Nonalcoholic Steatohepatitis, Type 2 Diabetes Mellitus | Phase 2 | 2016-09-30 |
| Completed | A Double Blind Open Label Comparator Study to Compare Treatments in 4 to 11 Year Old Patients With Asthma Asthma | Phase 1 | 2016-04-01 |
| Completed | To Assess Pharmacokinetics, Safety and Tolerability of TEV-48125 in Japanese and Caucasian Healthy Subjects Af Pharmacokinetics | Phase 1 | 2016-03-31 |
| Completed | Efficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic Mi Migraine | Phase 3 | 2016-03-23 |
| Completed | Comparing Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of TEV-48125 Versus Placebo fo Migraine | Phase 3 | 2016-03-22 |
| Completed | Efficacy and Safety of Subcutaneous Administration of Fremanezumab (TEV-48125) for the Preventive Treatment of Migraine | Phase 3 | 2016-02-26 |
| Completed | Study to Assess the Efficacy and Safety of Beclomethasone Dipropionate in Adolescent and Adult Patients 12 Yea Persistent Asthma | Phase 3 | 2015-09-30 |
| Completed | An Efficacy and Safety Study of Reslizumab Subcutaneous in Patients With Oral Corticosteroid Dependent Asthma Asthma, Elevated Blood Eosinophils, Oral Corticosteroid Dependence | Phase 3 | 2015-09-29 |
| Completed | Study of Reslizumab in Participants With Uncontrolled Asthma and Elevated Blood Eosinophils Asthma | Phase 3 | 2015-09-28 |
| Completed | Study to Evaluate the Analgesic Efficacy and Safety of Hydrocodone Bitartrate/Acetaminophen Immediate-Release Pain | Phase 3 | 2015-08-11 |
| Completed | Study to Assess Medication Satisfaction in Patients With Relapsing Remitting Multiple Sclerosis Treated With C Multiple Sclerosis | Phase 4 | 2015-08-10 |
| Completed | A Study to Evaluate 5 μg/kg Tbo-filgrastim in Infants, Children and Adolescents With Solid Tumors Without Bone Neutropenia | Phase 2 | 2015-05-12 |
| Completed | Study to Determine the Pharmacokinetics and Tolerability of Fluticasone Propionate MDPI and Fluticasone Propio Asthma | Phase 1 | 2015-05-01 |
| Terminated | Study of TV-1106 in Growth Hormone-Deficient Adults Growth Hormone Deficiency | Phase 3 | 2015-04-30 |
| Terminated | Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD) Growth Hormone Deficiency | Phase 3 | 2015-04-30 |
| Terminated | An Efficacy and Safety Profile of Inhaled TV48108 in Healthy Volunteers and COPD Patients Chronic Obstructive Pulmonary Disease | Phase 1 | 2015-04-01 |
| Terminated | Study in Healthy Volunteers and COPD Patients to Evaluate the Efficacy and Safety of Inhaled TV46017 Chronic Obstructive Pulmonary Disease (COPD | Phase 1 | 2015-03-01 |
| Completed | A Study to Evaluate the Safety and Efficacy of Topically Applied TV 45070 Ointment in Patients With Postherpet Postherpetic Neuralgia | Phase 2 | 2015-02-26 |
| Completed | A Phase 2 Clinical Study in Subjects With Primary Progressive Multiple Sclerosis to Assess the Efficacy, Safet Primary Progressive Multiple Sclerosis | Phase 2 | 2015-01-12 |
| Completed | A Clinical Study in Participants With Huntington's Disease (HD) to Assess Efficacy and Safety of Three Oral Do Huntington's Disease | Phase 2 | 2014-10-28 |
| Terminated | A Study to Evaluate the Pharmacokinetics, Safety,and Efficacy of Omacetaxine Given Subcutaneously as a Fixed D Chronic Myeloid Leukemia | Phase 1 / Phase 2 | 2014-10-09 |
| Withdrawn | Pharmacodynamics, Pharmacokinetics, Efficacy and Safety of Balugrastim in Pediatric Patients With Solid Tumors Solid Tumors | Phase 2 | 2014-09-01 |
| Completed | Study to Characterize the Pharmacokinetics and Safety of TV-45070 Ointment in Healthy Volunteers Pharmacokinetics | Phase 1 | 2014-08-01 |
| Withdrawn | A Study of 3 Doses of Tiotropium Hydrofluoralkane (HFA) Breath Actuated Inhaler (BAI), in Patients With Chroni Chronic Obstructive Pulmonary Disease, COPD | Phase 2 | 2014-08-01 |
| Completed | Long-Term Safety Study of Fluticasone Propionate (Fp) Multidose Dry Powder Inhaler (MDPI) and Fluticasone Prop Persistent Asthma | Phase 3 | 2014-07-01 |
| Completed | Study to Assess the Safety and Pharmacokinetics of ADASUVE® at Doses of 2.5, 5, or 10 mg in Children and Adole BiPolar | Phase 1 | 2014-07-01 |
| Completed | Study of Fluticasone Propionate MDPI Compared With Fluticasone/Salmeterol MDPI in Adolescent and Adult Patient Asthma | Phase 3 | 2014-06-01 |
| Completed | Efficacy and Safety Study of FP MDPI Compared With FS MDPI in Adolescent and Adult Patients With Persistent As Asthma | Phase 3 | 2014-06-01 |
| Completed | Study to Evaluate the Mastery of Inhaler Technique for Budesonide Formoterol (BF) SPIROMAX® as Compared to SYM Asthma | Phase 3 | 2014-05-28 |
| Completed | A Chronic-Dose Safety and Efficacy Study of Albuterol Multi-Dose Dry Powder Inhaler in Pediatric Asthmatics Asthma | Phase 3 | 2014-05-01 |
| Completed | A Study to Evaluate the Safety and Efficacy of Topically Applied TV-45070 (Ointment) in Participants With Prim Osteoarthritis of the Knee | Phase 2 | 2014-04-14 |
| Completed | A comparatiVe Study on Efficacy and Safety of Lipegfilgrastim in Comparison to Pegfilgrastim in Elderly Patien Aggressive B Cell Non-Hodgkin Lymphomas at High Risk for R-CHOP-21-induced Neutropenia | Phase 3 | 2014-03-31 |
| Completed | A Phase I Study in Young Healthy Women to Investigate the Effects of Laquinimod on Standard Oral Contraceptive Pharmacokinetics, Pharmacodynamics | Phase 1 | 2014-02-01 |
| Completed | A Pharmacokinetic Study to Evaluate the Bioequivalence of 2 Progesterone Vaginal Rings in Postmenopausal Women Pharmacokinetics | Phase 1 | 2014-02-01 |
| Completed | A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine Episodic Migraine Headache | Phase 2 | 2014-01-31 |
| Completed | Assessment of LBR-101 In Chronic Migraine Chronic Migraine | Phase 2 | 2014-01-31 |
| Withdrawn | A Study to Evaluate 2 Doses Of Oral Administration Of Laquinimod Compared to Interferon ß-1a Administered by I Relapsing Remitting Multiple Sclerosis | Phase 3 | 2014-01-01 |
| Completed | A 12-week Safety and Efficacy Study of Beclomethasone Dipropionate (80 and 160 mcg/Day) Delivered Via Breath-A Persistent Asthma | Phase 3 | 2013-12-26 |
| Completed | A Study to Investigate the Pharmacokinetics and Safety of Beclomethasone Dipropionate Administered by Breath-A Pharmacokinetics | Phase 1 | 2013-12-01 |
| Completed | A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Mete Asthma | Phase 3 | 2013-12-01 |
| Completed | A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Mete Asthma | Phase 3 | 2013-12-01 |
| Completed | Safety and Bioavailability of IV and SC LBR-101 Bioavailability and Pharmacokinetics | Phase 1 | 2013-10-01 |
| Completed | First Time Use of SD-809 in Huntington Disease Chorea | Phase 3 | 2013-08-05 |
| Completed | Pharmacokinetics and Pharmacodynamics (PK/PD) of CEP-26401 in Healthy Subjects Cognitive Impairment | Phase 1 | 2013-08-01 |
| Completed | Efficacy and Safety Evaluation of Budesonide/Formoterol SPIROMAX® Inhalation Powder Versus SYMBICORT® TURBOHAL Asthma | Phase 3 | 2013-07-04 |
| Completed | Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric Patient Asthma | Phase 2 | 2013-07-01 |
| Completed | To Determine the Maximum Tolerated Dose of Oral CEP-37440 in Patients With Advanced or Metastatic Solid Tumors Solid Tumors | Phase 1 | 2013-07-01 |
| Completed | An Open-Label Study to Investigate the Pharmacokinetics of Omacetaxine Mepesuccinate Hematologic Malignancies, Solid Tumors | Phase 1 | 2013-07-01 |
| Completed | Open-Label, Extension Study to Evaluate the Safety of Hydrocodone Bitartrate Extended-Release Tablets Low Back Pain | Phase 3 | 2013-07-01 |
| Completed | Absolute Bioavailability of Reslizumab in Healthy Subjects Absolute Bioavailability | Phase 1 | 2013-06-01 |
| Completed | Safety and Tolerability of Glatiramer Acetate Relapsing-Remitting Multiple Sclerosis | Phase 3 | 2013-06-01 |
| Completed | Efficacy and Safety of TV-1380 as Treatment for Facilitation of Abstinence in Cocaine-Dependent Subjects Cocaine Addiction | Phase 2 | 2013-06-01 |
| Completed | A Study to Assess the Pharmacokinetics, Safety, and Tolerability of Single and Multiple Doses of Rasagiline Parkinson's Disease | Phase 1 | 2013-06-01 |
| Completed | Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI) Asthma, Chronic Obstructive Pulmonary Disease (COPD) | Phase 3 | 2013-05-01 |
| Completed | Pharmacokinetic and Pharmacodynamic Profiles of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Ped Asthma | Phase 1 | 2013-04-01 |
| Completed | Safety, Tolerability and Efficacy of Weekly TV-1106 in Adults With Growth Hormone Deficiency Growth Hormone Deficiency | Phase 2 | 2013-03-31 |
| Completed | Efficacy of Albuterol SPIROMAX® in Adult and Adolescent Patients With Exercise-Induced Bronchoconstriction (EI Exercise-Induced Bronchoconstriction (EIB) | Phase 3 | 2013-03-01 |
| Completed | Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets for Moderate to Severe Chronic Low Back Low Back Pain | Phase 3 | 2013-03-01 |
| Completed | The Efficacy, Safety, and Tolerability of Laquinimod in Participants With Relapsing Remitting Multiple Scleros Multiple Sclerosis | Phase 3 | 2013-02-20 |
| Completed | A Crossover Study to Assess the Bioequivalence of Hydrocodone Bitartrate Extended-Release Tablet Pain | Phase 1 | 2013-01-01 |
| Completed | Dose Ranging Study of the Salmeterol Component of Fluticasone /Salmeterol Spiromax Compared to Fluticasone Spi Asthma | Phase 2 | 2013-01-01 |
| Completed | To Compare the Pharmacokinetics of Tiotropium in Subjects With Chronic Obstructive Pulmonary Disease (COPD) COPD | Phase 1 / Phase 2 | 2013-01-01 |
| Completed | Study of an Investigational Nasal Aerosol or Placebo in Children (Ages 4 to 11) With Perennial Allergic Rhinit Allergic Rhinitis | Phase 3 | 2013-01-01 |
| Completed | Efficacy of Inhaled Albuterol Spiromax® in Subjects With Persistent Asthma With Steady State Pharmacokinetics Asthma | Phase 3 | 2012-12-01 |
| Completed | A Crossover Study to Assess the Bioequivalence of Hydrocodone Bitartrate Extended-Release Tablet Pain | Phase 1 | 2012-12-01 |
| Completed | A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years Asthma | Phase 3 | 2012-12-01 |
| Completed | Parallel-Group Study to Assess the Effect of Rasagiline on Cognition in Patients With Parkinson's Disease Parkinson's Disease | Phase 4 | 2012-11-01 |
| Completed | Hypothalamic-Pituitary-Adrenal (HPA)-Axis Study in Pediatric Subjects With Perennial Allergic Rhinitis (PAR) Allergic Rhinitis | Phase 3 | 2012-10-01 |
| Completed | Safety Study of Albuterol Spiromax® in Subjects With Asthma Asthma | Phase 3 | 2012-10-01 |
| Completed | A Study of Bendamustine in the Treatment of Chinese Participants With Indolent Non-Hodgkin Lymphoma Refractory Non-Hodgkin Lymphoma | Phase 3 | 2012-08-06 |
| Completed | Effectiveness of Beclomethasone Dipropionate Nasal Aerosol for Perennial Allergic Rhinitis Perennial Allergic Rhinitis (PAR) | — | 2012-07-01 |
| Completed | Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Armodafinil in Children and Adolescent Narcolepsy | Phase 1 | 2012-07-01 |
| Completed | A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder I Asthma | Phase 2 | 2012-04-01 |
| Terminated | An Efficacy, Safety and Tolerability Study of Glatiramer Acetate (GA) 20 mg/0.5 ml New Formulation Administere Relapsing-Remitting Multiple Sclerosis | Phase 3 | 2012-03-01 |
| Withdrawn | A Multinational, Randomized, Double-blind, Parallel-group, Placebo-controlled Study Assessing the Safety and T Relapsing Multiple Sclerosis | Phase 2 | 2012-03-01 |
| Completed | Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma Eosinophilic Asthma | Phase 3 | 2012-02-01 |
| Completed | A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder I Asthma | Phase 2 | 2012-01-01 |
| Withdrawn | Adenovirus Vaccine Pregnancy Registry Adenovirus | — | 2011-12-01 |
| Completed | A Multinational Study to Evaluate the Effects of a 28-Day Oral Contraceptive on Hemostatic Parameters in Healt Hemostasis, Oral Contraceptive | Phase 2 | 2011-10-31 |
| Completed | Delanzomib (CEP-18770) in Combination With Lenalidomide and Dexamethasone in Relapsed or Refractory Multiple M Multiple Myeloma | Phase 1 / Phase 2 | 2011-08-03 |
| Terminated | Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of Reslizumab (3.0 mg/kg) as Treatmen Eosinophilic Asthma | Phase 3 | 2011-06-01 |
| Terminated | Study to Determine the Maximum Tolerated Dose of the PARP Inhibitor CEP-9722 in Participants With Solid Tumors Solid Tumors | Phase 1 / Phase 2 | 2011-05-02 |
| Completed | A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exac Eosinophilic Asthma | Phase 3 | 2011-04-01 |
| Completed | Study of an Investigational Nasal Aerosol or Placebo Nasal Aerosol in Children (Ages 6-11) With Seasonal Aller Seasonal Allergic Rhinitis, SAR | Phase 3 | 2011-03-01 |
| Completed | A Study to Evaluate the Efficacy and Safety of Reslizumab in Patients With Eosinophilic Asthma Eosinophilic Asthma | Phase 3 | 2011-03-01 |
| Completed | A Study to Evaluate the Integrated Dose Counter on an Albuterol Hydrofluoroalkane (HFA) Metered Dose Inhaler ( Asthma, Chronic Obstructive Pulmonary Disease (COPD), Emphysema | — | 2011-03-01 |
| Completed | A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Eosinophilic Asthma | Phase 3 | 2011-02-01 |
| Completed | A Study to Evaluate Ovarian Follicular Activity and Hormone Levels for DR-102 Compared to Two 28-Day Oral Cont Follicle Development, Ovarian Follicle, Follicle Count | Phase 1 | 2011-01-31 |
| Completed | Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) for R Chronic Pain | Phase 3 | 2010-11-01 |
| Completed | A Study of Laquinimod in Participants With Systemic Lupus Erythematosus (SLE) Active Lupus Arthritis Lupus Arthritis | Phase 2 | 2010-10-04 |
| Completed | Study to Evaluate the Long-Term Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) in Patie Chronic Pain | Phase 3 | 2010-10-01 |
| Terminated | A Twelve Month Long Term Safety Study to Evaluate the Safety of Albuterol in a Dry Powder Inhaler With Both Re Asthma | Phase 3 | 2010-10-01 |
| Completed | A Study of Laquinimod in Participants With Systemic Lupus Erythematosus (SLE) Active Lupus Nephritis Lupus Nephritis | Phase 2 | 2010-09-01 |
| Completed | A Double-blind, Randomized Controlled Study in CD20-positive Diffuse B Cell Non-Hodgkin's Lymphoma Subjects DLBCL | Phase 1 | 2010-09-01 |
| Completed | A Study to Evaluate the Efficacy and Safety of DR-102 for the Prevention of Pregnancy Contraception, Female Contraception | Phase 3 | 2010-08-01 |
| Completed | Study of Bendamustine Hydrochloride for the Treatment of Pediatric Patients With Relapsed or Refractory Acute Leukemia | Phase 1 / Phase 2 | 2010-08-01 |
| Completed | Neugranin in Breast Cancer Participants Receiving Doxorubicin/Docetaxel Chemotherapy-induced Neutropenia | Phase 3 | 2010-06-30 |
| Completed | A Study in Subjects With Relapsing-Remitting Multiple Sclerosis (RRMS) to Assess the Efficacy, Safety and Tole Relapsing Remitting Multiple Sclerosis | Phase 3 | 2010-06-22 |
| Completed | Hypothalamic-Pituitary-Adrenal (HPA) Axis Study in Adult and Adolescent Subjects With Perennial Allergic Rhini Perennial Allergic Rhinitis | Phase 3 | 2010-06-01 |
| Terminated | A Study to Evaluate the Long-term Safety, Tolerability and Effect of Daily Oral Laquinimod 0.6 mg on Disease C Relapsing Multiple Sclerosis | Phase 3 | 2010-05-27 |
| Completed | Cost-effectiveness Study of miRview™ Mets in Patients With Cancer of Unknown Primary (CUP) Neoplasms, Unknown Primary | — | 2010-05-01 |
| Completed | Laquinimod Phase IIa Study in Active Crohn's Disease Crohn's Disease | Phase 2 | 2010-05-01 |
| Completed | Study in Adult and Adolescent Subjects With PAR (Perennial Allergic Rhinitis) Rhinitis, Allergic, Perennial | Phase 3 | 2010-05-01 |
| Completed | A Dose-ranging Study to Evaluate Albuterol and Hydrofluoroalkane in Subjects Ages 12 and Older With Persistent Asthma | Phase 2 | 2010-02-01 |
| Completed | A Cumulative Dose Study to Evaluate the Safety and Efficacy of Albuterol in a Dry Powder Inhaler and an HFA MD Asthma | Phase 1 | 2010-01-01 |
| Completed | Study in Adult and Adolescent Subjects With Seasonal Allergic Rhinitis (SAR) Seasonal Allergic Rhinitis, Hay Fever | Phase 3 | 2009-12-31 |
| Completed | Clinical Trial to Assess Efficacy, Safety, and Tolerability of Rasagiline Mesylate 1 mg in Patients With Multi Multiple System Atrophy | Phase 2 | 2009-12-01 |
| Completed | Study for Rasagiline Effect on Sleep Trial(REST)in Parkinson's Disease Parkinson's Disease | — | 2009-12-01 |
| Terminated | A Study To Evaluate the Long-Term Safety, Tolerability and Effect on Disease Course Relapsing Multiple Sclerosis | Phase 3 | 2009-11-10 |
| Completed | Long Term Safety and Efficacy Trial of Beclomethasone Dipropionate - Hydrofluoroalkane (BDP-HFA) 320 mcg in Al Rhinitis, Allergic, Perennial | Phase 3 | 2009-10-31 |
| Completed | A Phase 1 Study to Investigate the Effects of Talampanel on the Heart Rhythm Healthy | Phase 1 | 2009-10-01 |
| Terminated | Extension Study of Talampanel for Amyotrophic Lateral Sclerosis (ALS) Amyotrophic Lateral Sclerosis | Phase 2 | 2009-09-01 |
| Completed | Comparison of a Needle-free Injection Method With a Needle-syringe Injection Method Growth Hormone Deficiency | Phase 4 | 2009-09-01 |
| Terminated | Comparative Bioavailability of Myfenax® and CellCept® in Kidney Transplant Patients Stable Renal Transplant Recipients | Phase 4 | 2009-08-01 |
| Completed | ADAGIO Follow Up Study: Evaluation of the Long-Term Effects of Rasagiline in Parkinson's Disease Subjects Parkinson's Disease | — | 2009-07-01 |
| Completed | Azilect + Antidepressant Chart Review Serotonin Syndrome | — | 2009-07-01 |
| Completed | Safety of New Formulation of Glatiramer Acetate Relapsing Remitting Multiple Sclerosis | Phase 3 | 2009-07-01 |
| Completed | Bradykinesia Subscale Administered Alone Versus Regular Administration: Psychometric Properties Parkinson's Disease | — | 2009-06-01 |
| Terminated | A Study to Investigate the Absorption, Metabolism and Excretion of Talampanel Healthy | Phase 1 | 2009-05-01 |
| Completed | Study of Bendamustine Hydrochloride and Rituximab (BR) Compared With R-CVP or R-CHOP in the First-Line Treatme Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma | Phase 3 | 2009-04-30 |
| Completed | Clinical Study to Evaluate the Pharmacokinetics and Safety of BDP HFA Nasal Aerosol Allergic Rhinitis | Phase 1 | 2009-03-01 |
| Completed | Study to Assess the Efficacy and Safety of BDP HFA Nasal Aerosol in Patients 12 Years and Older With SAR Seasonal Allergic Rhinitis, Hayfever | Phase 2 | 2009-03-01 |
| Completed | A Randomized, Double-blind, Placebo-controlled, Multicenter Study of the Effects of Glatiramer Acetate (GA) on Optic Neuritis | Phase 3 | 2009-02-01 |
| Completed | A Study of Pridopidine (ACR16) for the Treatment of Participants With Huntington's Disease Huntington Disease | Phase 2 | 2008-10-24 |
| Completed | Talampanel for Amyotrophic Lateral Sclerosis (ALS) ALS | Phase 2 | 2008-09-01 |
| Completed | Balugrastim (Neugranin) in Breast Cancer Participants Receiving Doxorubicin/Docetaxel Chemotherapy-induced Neutropenia | Phase 2 / Phase 3 | 2008-08-21 |
| Completed | A Study of Treatment With Pridopidine (ACR16) in Participants With Huntington's Disease Huntington's Disease | Phase 3 | 2008-04-24 |
| Completed | BRAVO Study: Laquinimod Double-blind Placebo-controlled Study in Participants With Relapsing-Remitting Multipl Multiple Sclerosis | Phase 3 | 2008-04-24 |
| Completed | Safety and Efficacy of Orally Administered Laquinimod Versus Placebo for Treatment of Relapsing Remitting Mult Multiple Sclerosis | Phase 3 | 2007-11-13 |
| Completed | A Study to Evaluate Hormone Patterns and Ovarian Follicular Activity With DR-1021 Healthy | Phase 3 | 2007-10-31 |
| Completed | Albuterol HFA MDI in Pediatric Participants With Asthma Asthma | Phase 3 | 2007-08-01 |
| Completed | Comparison of Single-Dose Efficacy of an Albuterol Breath-Actuated Inhaler (Albuterol-HFA-BAI) Versus an Albut Asthma | Phase 4 | 2007-07-25 |
| Completed | Open Label Study of Subcutaneous Homoharringtonine (Omacetaxine Mepesuccinate) in Patients With Advanced CML Chronic Myeloid Leukemia | Phase 2 | 2007-03-07 |
| Completed | Effects of Talampanel on Patients With Advanced Parkinson's Disease Dyskinesias, Parkinson Disease, Movement Disorders | Phase 1 / Phase 2 | 2006-12-01 |
| Completed | Homoharringtonine (Omacetaxine Mepesuccinate) in Treating Patients With Chronic Myeloid Leukemia (CML) With th Chronic Myeloid Leukemia | Phase 2 | 2006-09-20 |
| Completed | Clinical Trial Comparing Treatment of Relapsing-Remitting Multiple Sclerosis (RR-MS) With Two Doses of Glatira Relapsing Remitting Multiple Sclerosis | Phase 3 | 2006-08-01 |
| Completed | Determine Impact of Multiple NAb Tests on Treatment Compared to Usual Care of MS Patients on High-dose IFN The Multiple Sclerosis | — | 2006-07-01 |
| Completed | Chronic-Dose Safety and Efficacy Study of Albuterol-HFA-BAI in Pediatric Asthmatics Asthma | Phase 3 | 2006-06-10 |
| Completed | Safety and Efficacy of Talampanel in Glioblastoma Multiforme Glioblastoma Multiforme | Phase 2 | 2005-12-01 |
| Completed | A Randomized Placebo Controlled Study to Show That Rasagiline May Slow Disease Progression for Parkinson's Dis Parkinson's Disease | Phase 3 | 2005-11-01 |
| Completed | A Study to Evaluate the Long Term Safety and Effectiveness of Novantrone Therapy Followed by Copaxone Treatmen Relapsing Remitting Multiple Sclerosis | — | 2005-10-01 |
| Completed | Efficacy/Safety Study of Nebulized IVX-0142, a Novel Antiallergic Drug, in Mild Allergic Asthma Asthma | Phase 2 | 2005-10-01 |
| Completed | Non-invasive Measures of Distal Lung Disease in Asthmatics Asthma | Phase 4 | 2005-09-30 |
| Terminated | A Study to Evaluate the Tolerability, Safety and Effectiveness of Edratide in the Treatment of Lupus Systemic Lupus Erythematosus | Phase 2 | 2005-07-01 |
| Completed | Comparison of Two Bronchodilator Inhalers in Pediatric Asthmatics Asthma | Phase 2 | 2005-06-30 |
| Completed | A Study to Evaluate the Effectiveness, Tolerability and Safety of Laquinimod Relapsing Remitting Multiple Sclerosis | Phase 2 | 2005-03-01 |
| Terminated | Assessment Study of Steroid Effect in Relapsing Multiple Sclerosis Subjects Treated With Glatiramer Acetate Relapsing Remitting Multiple Sclerosis | Phase 4 | 2005-01-01 |
| Completed | Safety and Efficacy Study to Treat Recurrent Grade 4 Malignant Brain Tumors Glioblastoma Multiforme | Phase 2 | 2004-12-01 |
| Completed | Safety and Efficacy Study of Copaxone Administered in Combination With N-Acetylcysteine Relapse Remitting Multiple Sclerosis | Phase 2 | 2004-12-01 |
| Completed | Evaluation of Two Doses of QVAR by Breath Operated and Metered Dose Inhalers in Asthmatic Children Asthma | Phase 3 | 2004-10-31 |
| Completed | A Study to Evaluate the Impact on Skin (Injection Site) Reactions of Taking an Antihistamine (Zyrtec®) or Plac Multiple Sclerosis | Phase 4 | 2004-10-01 |
| Completed | Rasagiline 1 mg and 2 mg Added to Aricept 10 mg Daily in Patients With Mild to Moderate Alzheimer's Disease (A Dementia, Alzheimer's Disease | Phase 2 | 2004-08-01 |
| Completed | Evaluation of Two Doses of QVAR Versus Placebo by Breath Operated and Metered Dose Inhalers in Moderate Asthma Asthma | Phase 3 | 2004-07-31 |
| Terminated | Randomized Study Designed to Look at Disease Progression Using 2 Currently FDA Approved Drugs for the Treatmen Relapsing Remitting Multiple Sclerosis | Phase 4 | 2004-07-01 |
| Completed | Comparison of Two Bronchodilator Inhalers in Adolescents and Adults With Exercise-Induced Asthma Exercise-induced Bronchospasm | Phase 3 | 2004-06-30 |
| Completed | Safety and Efficacy Study of Copaxone Administered in Combination With Minocycline Relapse Remitting Multiple Sclerosis | Phase 2 | 2004-06-01 |
| Completed | Safety, Tolerability, and Effectiveness of Rasagiline Mesylate in Patients With Parkinson's Disease Parkinson's Disease | Phase 3 | 2004-06-01 |
| Terminated | Efficacy of QVAR vs Flovent Diskus on Small Airways in Poorly Controlled Asthmatic Adolescents/Adult Patients Asthma | Phase 4 | 2004-01-31 |
| Completed | Evaluate Early Glatiramer Acetate Treatment in Delaying Conversion to Clinically Definite Multiple Sclerosis o Multiple Sclerosis | Phase 3 | 2004-01-01 |
| Completed | Safety and Efficacy Study to Treat Recurrent Grade 4 Malignant Brain Tumors Recurrent Glioblastoma Multiforme | Phase 2 | 2003-10-01 |
| Completed | A Study to Test the Effectiveness and Safety of a New Higher 40mg Dose of Copaxone® Compared to Copaxone® 20mg Relapse-Remitting Multiple Sclerosis | Phase 2 | 2003-08-01 |
| Terminated | Phase 2 Trial Using Talampanel in Patients With Recurrent High Grade Gliomas Glioblastoma Multiforme, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma | Phase 2 | 2003-07-01 |
| Completed | A Study to Evaluate the Safety and Effectiveness of Novantrone Therapy Followed by Copaxone for Multiple Scler Relapsing Remitting Multiple Sclerosis | Phase 2 | 2003-06-01 |
| Completed | Comparative Effectiveness of a Breath-operated Albuterol Inhaler in Asthma Patients With Poor Inhaler Techniqu Asthma | Phase 2 | 2003-03-31 |
| Completed | A Survey Study to See if Patients Diagnosed With Parkinson's Disease Have Higher Incidence of Melanoma Parkinson's Disease, Malignant Melanoma | — | 2003-01-01 |
| Completed | Study to Evaluate the Safety and Tolerability of Rasagiline in Advanced Parkinson's Disease Patients Parkinson's Disease | Phase 3 | 2002-05-01 |
| Completed | Multicenter Trial For Patients With Acute Crohn's Disease Crohn's Disease | Phase 2 | 2002-01-31 |
| Completed | Multicenter Trial for Adults With Partial Seizures Epilepsy | Phase 2 | 2002-01-01 |
| Completed | Rasagiline in Advanced Parkinson's Disease Patients With Motor Fluctuations Treated With Levodopa/Carbidopa Th Parkinson's Disease | Phase 3 | 2001-10-01 |
| Completed | A Study to Evaluate the Effects of Tyramine in Patients Who Completed the PRESTO Study. Parkinson's Disease | Phase 3 | 2000-10-01 |
| Completed | Multicenter Study of Rasagiline in Parkinson's Disease Patients Using Levodopa and Experiencing Motor Fluctuat Parkinson's Disease | Phase 3 | 2000-05-01 |
| Completed | Glatiramer Acetate (Copaxone®) Study to Follow Participants From the First Original Study for Safety and Effec Relapsing-Remitting Multiple Sclerosis | Phase 4 | 1994-03-26 |
| Available | Fremanezumab Compassionate Use Program for Pediatric Patients Migraine | — | — |